Beaumont Financial Advisors, LLC Bristol Myers Squibb CO Transaction History
Beaumont Financial Advisors, LLC
- $1.14 Billion
- Q4 2024
A detailed history of Beaumont Financial Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beaumont Financial Advisors, LLC holds 11,723 shares of BMY stock, worth $658,246. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,723
Previous 11,625
0.84%
Holding current value
$658,246
Previous $601,000
10.32%
% of portfolio
0.06%
Previous 0.05%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,690Shares Held
1.53BCall Options Held
32MPut Options Held
35.4M-
Vanguard Group Inc Valley Forge, PA190MShares$10.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.91 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.39 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.22 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.39 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...